3D Executive Search Partners’ Post

Sjogrens Syndrome Therapeutics Market report from 2022-2027 by Technavio - The market size to grow by USD 691.09 million during the forecast period: NEW YORK, Dec. 14, 2023 /PRNewswire/ -- The Sjogren's Syndrome Therapeutics Market size is anticipated to witness substantial growth between 2022 and 2027, projecting an estimated increase of USD 691.09 million at a compound annual growth rate (CAGR) of 6.53%. This market is driven by the...

Day 1: Working on #oligonucleotide-based therapies? Connect with our WuXi TIDES team at the 9th OPT Congress in Boston from March 13-14. On March 13 at 12:45 pm EST, Yvonne Angell, Ph.D., our Executive Director and Head of TIDES discovery project management, will outline the technical challenges encountered in the discovery phase of oligonucleotide therapeutics. Through two case studies, we’ll detail our strategies for advancing programs from discovery to development, addressing technical obstacles and optimizing our approach. This presentation will offer practical insights for navigating the complexities of oligonucleotide therapy development.   Schedule a meeting with our team: WuXi_TIDES@wuxiapptec.com Learn more: https://lnkd.in/g6AmChYd #WuXiTIDES #peptides #oligonucleotides #CRDMO

Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar: The global GEP-NET therapeutics market is further expected to increase by the major drivers such as rising incident population, technological advancements, increased funding for new drug development and clinical trials, increasing awareness among common people, increasing research...

As per DelveInsight’s analysis, the estimated total diagnosed prevalent Amyotrophic Lateral Sclerosis (ALS) cases in the 7MM were approximately 500K in 2022.  The ALS market size in the 7MM was approximately USD 500 million in 2022, which is expected to grow by 2032. Some of the leading pharma and biotech giants in the Amyotrophic Lateral Sclerosis market include Helixmith, Sanofi, Denali Therapeutics, Alector, GSK, NeuroSense Therapeutics, Biogen, Ionis Pharmaceuticals, Inc., Brainstorm Cell Therapeutics, Cytokinetics, Astellas Pharma, Apellis Pharmaceuticals, Clene Nanomedicine, MediciNova, Inc., Seelos Therapeutics, Inc., Prilenia, AB Science, Eledon Pharmaceuticals, Inc., Revalesio Corporation, Biohaven, UCB, Ra Pharmaceuticals, AI Therapeutics, and others. Learn More: https://lnkd.in/dCfic7-p #healthcarejob #biotechnology #lifesciences #pharmaceutical #market #marketforecast #marketanalysis #clinicaltrials #clinicalresearch #fda #healthcaremarket #healthcareindustry #marketoutlook #amyotrophiclateralsclerosis

Join our webinar with Cuong Do, founder and Chairman of M6P Therapeutics, to hear how their breakthrough technology is driving the development of the next generation of enzyme replacement therapies for a wide range of conditions. July 23 at 11 AM ET https://hubs.la/Q02GYRkw0

Join our webinar with Cuong Do, founder and Chairman of M6P Therapeutics, to hear how their breakthrough technology is driving the development of the next generation of enzyme replacement therapies for a wide range of conditions. July 23 at 11 AM ET https://hubs.la/Q02GYPpY0

𝐍𝐞𝐰𝐬 𝐚𝐛𝐨𝐮𝐭 𝐈𝐧𝐭𝐚𝐯𝐢𝐬 𝐏𝐞𝐩𝐭𝐢𝐝𝐞 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 Personalize medicine based on peptide has made great progress in recent years. As more and more clinical projects were initiated the demand for small scale GMP grade peptides was also picking up quickly. Hence, Intavis Peptide Services decided in 2019 to build 𝐚 𝐆𝐌𝐏 𝐀𝐏𝐈 𝐟𝐚𝐜𝐢𝐥𝐢𝐭𝐲. Lo and behold, we are on schedule and eagerly await the opening ceremonies planned for Q4 of 2024. If you are you planning any 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐨𝐧 𝐩𝐞𝐩𝐭𝐢𝐝𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬, don’t hesitate to check out 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞. #gmp #drugdevelopment #peptides #clinicaltrials #intavis

mRNA Therapeutics Global Market Report Outlook to 2028 - A $21 Billion Market by 2028, with Decline of -8.6% Since 2022: DUBLIN, Dec. 29, 2023 /PRNewswire/ -- The "mRNA: Therapeutics and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA therapeutics reached $60 billion in 2022 and is estimated to reach $21 billion by the end of 2028. It is expected to...

Catch up on a webinar, the Lumit™ FcRn Binding Immunoassay as a tool in the development of antibody-based therapeutics – Users share their experiences. Viewers will gain an understanding of Lumit™ Immunoassays, their applications, and how they simplify #FcRn binding analysis. https://bit.ly/3uTSIWK

Join our webinar with Cuong Do, founder and Chairman of M6P Therapeutics, to hear how their breakthrough technology is driving the development of the next generation of enzyme replacement therapies for a wide range of conditions. July 23 at 11 AM ET https://hubs.la/Q02GY-6z0